Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Oncolys BioPharma

2004 FOUNDED
PUBLIC STATUS
31-40 EMPLOYEES
4588 STOCK SYMBOL
2 INVESTMENTS
$25.55 SHARE PRICE (As of Friday Closing)
Description

Oncolys BioPharma Inc. develops pharmaceutical products. The company is engaged in research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents.

Website
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Primary Office
  • Toranomon Towers Office
  • 4-1-28 Toranomon
  • Tokyo, Minato-ku 105-0001
  • Japan

+81 00-0000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Oncolys BioPharma’s full profile, request a free trial.

Oncolys BioPharma Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$4.26 - $39.66 $342M $25.91 -$0.95 5.13M 13.4M

Oncolys BioPharma Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 103,330 99,321 57,302 59,238
Revenue 1,526 1,526 2,043 1,639
EBITDA (11,291) (11,291) (9,687) (8,406)
Net Income (11,172) (11,172) (9,724) (8,560)
Total Assets 31,084 31,084 31,278 26,850
Total Debt 3,639 3,639 4,034 3,321
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Oncolys BioPharma Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 31-Mar-2017 000000000 00000 Medical Supplies
Liquid Biotech 02-Dec-2015 Seed Round 000 Other Healthcare Technology Systems
To view this company’s complete investment and acquisition history, request access »

Oncolys BioPharma Executive Team (1)

Name Title Board
Seat
Contact
Info
Namiko Yamashita Ph.D Senior Manager, Business Development